These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27789271)

  • 1. Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.
    Jian J; Tian QY; Hettinghouse A; Zhao S; Liu H; Wei J; Grunig G; Zhang W; Setchell KDR; Sun Y; Overkleeft HS; Chan GL; Liu CJ
    EBioMedicine; 2016 Nov; 13():212-224. PubMed ID: 27789271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with ERp57 is required for progranulin protection against Type 2 Gaucher disease.
    Liu Y; Zhao X; Jian J; Hasan S; Liu C
    Biosci Trends; 2023 May; 17(2):126-135. PubMed ID: 36889696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Progranulin and Gaucher Disease.
    Jian J; Zhao S; Tian QY; Liu H; Zhao Y; Chen WC; Grunig G; Torres PA; Wang BC; Zeng B; Pastores G; Tang W; Sun Y; Grabowski GA; Kong MX; Wang G; Chen Y; Liang F; Overkleeft HS; Saunders-Pullman R; Chan GL; Liu CJ
    EBioMedicine; 2016 Sep; 11():127-137. PubMed ID: 27515686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects,
    Zhao X; Lin Y; Liou B; Fu W; Jian J; Fannie V; Zhang W; Setchell KDR; Grabowski GA; Sun Y; Liu CJ
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2210442120. PubMed ID: 36574647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
    Chen Y; Jian J; Hettinghouse A; Zhao X; Setchell KDR; Sun Y; Liu CJ
    J Mol Med (Berl); 2018 Dec; 96(12):1359-1373. PubMed ID: 30341570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice.
    van der Lienden MJC; Aten J; Marques ARA; Waas ISE; Larsen PWB; Claessen N; van der Wel NN; Ottenhoff R; van Eijk M; Aerts JMFG
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease.
    Lin Y; Zhao X; Liou B; Fannin V; Zhang W; Setchell KDR; Wang X; Pan D; Grabowski GA; Liu CJ; Sun Y
    Hum Mol Genet; 2024 Oct; 33(20):1771-1788. PubMed ID: 39101473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
    Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
    SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.
    Jian J; Chen Y; Liberti R; Fu W; Hu W; Saunders-Pullman R; Pastores GM; Chen Y; Sun Y; Grabowski GA; Liu CJ
    EBioMedicine; 2018 Feb; 28():251-260. PubMed ID: 29396296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase.
    Fog CK; Zago P; Malini E; Solanko LM; Peruzzo P; Bornaes C; Magnoni R; Mehmedbasic A; Petersen NHT; Bembi B; Aerts JFMG; Dardis A; Kirkegaard T
    EBioMedicine; 2018 Dec; 38():142-153. PubMed ID: 30497978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin associates with Rab2 and is involved in autophagosome-lysosome fusion in Gaucher disease.
    Zhao X; Liberti R; Jian J; Fu W; Hettinghouse A; Sun Y; Liu CJ
    J Mol Med (Berl); 2021 Nov; 99(11):1639-1654. PubMed ID: 34453183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes.
    Jian J; Hettinghouse A; Liu CJ
    Genes Dis; 2017 Sep; 4(3):125-126. PubMed ID: 28944282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin deficiency leads to reduced glucocerebrosidase activity.
    Zhou X; Paushter DH; Pagan MD; Kim D; Nunez Santos M; Lieberman RL; Overkleeft HS; Sun Y; Smolka MB; Hu F
    PLoS One; 2019; 14(7):e0212382. PubMed ID: 31291241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular regulations and therapeutic targets of Gaucher disease.
    Chen Y; Sud N; Hettinghouse A; Liu CJ
    Cytokine Growth Factor Rev; 2018 Jun; 41():65-74. PubMed ID: 29699937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
    Pavan E; Peruzzo P; Cattarossi S; Bergamin N; Bordugo A; Sechi A; Scarpa M; Biasizzo J; Colucci F; Dardis A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.
    Bae EJ; Yang NY; Lee C; Lee HJ; Kim S; Sardi SP; Lee SJ
    Exp Mol Med; 2015 Mar; 47(3):e153. PubMed ID: 25813221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones.
    Yang C; Swallows CL; Zhang C; Lu J; Xiao H; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):249-54. PubMed ID: 24351928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
    Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
    Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease.
    Srikanth MP; Feldman RA
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease.
    Dobert JP; Bub S; Mächtel R; Januliene D; Steger L; Regensburger M; Wilfling S; Chen JX; Dejung M; Plötz S; Hehr U; Moeller A; Arnold P; Zunke F
    Adv Sci (Weinh); 2024 Jul; 11(25):e2401641. PubMed ID: 38666485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.